9:00 AM - 5:00 PM

Our Hours Mon. - Fri.

310.774.1437

Call Us For Free Consultation

Facebook

Twitter

Cancer Biotech, 2 Others Score IPOs Totaling $279M

Tiomkin Law Offices of Elliott Tiomkin > Legal News  > Cancer Biotech, 2 Others Score IPOs Totaling $279M

Cancer Biotech, 2 Others Score IPOs Totaling $279M

Law360 (April 17, 2019, 7:13 PM EDT) — Cancer-focused biotechnology firm Turning Point Therapeutics made its public debut Wednesday, recording the most lucrative initial public offering of three companies that brought in a combined $279 million.

Cooley LLP-led Turning…

Call Now ButtonCall For Free Consultation